Dr. Poonam Mishra is the Deputy Director for Safety in the Division of Antivirals, in the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). She shares the responsibility for overseeing the safety of antiviral drug products to ensure that the benefits of approved drugs outweigh their known risks. Dr. Mishra joined FDA in 2008 as a Medical Officer in the Division of Antiviral Products where she has been involved in the regulatory review of multiple antiviral products, including direct-acting antivirals for the treatment of chronic hepatitis C. She is actively involved in the drug development of novel therapies for treatment of chronic hepatitis B and chronic hepatitis D virus infection. Dr. Mishra also has a strong interest in the evaluation of drug-induced liver injury particularly in patients with pre-existing chronic liver disease.
